Item 5. Other Information
Item 5. Other Information
Rule 10b5-1 Trading Arrangements
The following table describes contracts, instructions, or written plans for the purchase or sale of our securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), entered into during the quarter ended June 29, 2024. There were no non-Rule 10b5-1 trading arrangements entered into or terminated during the quarter ended June 29, 2024.
Name and Title of Director or Officer Date of Adoption of Arrangement Duration of the Arrangement Aggregate Number of Securities to be Purchased or Sold Pursuant to the Arrangement
Brandon Tolany
Senior VP, Worldwide Sales, Marketing & Applications
May 29, 2024 Expires May 30, 2025
4,117
William Bock
Director
May 7, 2024 Expires May 30, 2025
4,000
Navdeep Sooch
Chairman of the Board
May 22, 2024 Expires May 21, 2026
45,000
38
Table of Contents
Item 6. Exhibits
The following exhibits are filed as part of this report:
Exhibit
Number
2.1* Asset Purchase Agreement dated April 22, 2021 between Silicon Laboratories Inc. and Skyworks Solutions, Inc. (filed as Exhibit 2.1 to the Form 8-K filed on April 22, 2021).
3.1* Form of Fourth Amended and Restated Certificate of Incorporation of Silicon Laboratories Inc. (filed as Exhibit 3.1 to the Registration Statement on Form S-1 (Securities and Exchange Commission File No. 333-94853) (the “IPO Registration Statement”)).
3.2* Sixth Amended and Restated Bylaws of Silicon Laboratories Inc. (filed as Exhibit 3.1 to the Form 8-K filed on April 21, 2023).
4.1* Specimen certificate for shares of common stock (filed as Exhibit 4.1 to the IPO Registration Statement).
10.1* Silicon Laboratories Inc. 2024 Bonus Plan (filed as Exhibit 10.1 to the Form 10-K filed on January 31, 2024.
31.1 Certification of the Principal Executive Officer, as required by Section 302 of the Sarbanes-Oxley Act of 2002.
31.2 Certification of the Principal Financial Officer, as required by Section 302 of the Sarbanes-Oxley Act of 2002.
32.1** Certification as required by Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCH Inline XBRL Taxonomy Extension Schema Document
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document
101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document
104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
______________________________________________
* Incorporated herein by reference to the indicated filing.
** Furnished herewith.
39
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
SILICON LABORATORIES INC.
July 24, 2024 /s/ R. Matthew Johnson
Date R. Matthew Johnson
President and
Chief Executive Officer
(Principal Executive Officer)
July 24, 2024 /s/ Dean Butler
Date Dean Butler
Senior Vice President and
Chief Financial Officer
(Principal Financial Officer)
July 24, 2024 /s/ Mark D. Mauldin
Date Mark D. Mauldin
Chief Accounting Officer
(Principal Accounting Officer)
40
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.